Frequently Asked Questions (FAQ): COVID-19 Vaccine Distribution Considerations for the Disability Community

Posted on December 10, 2020

AUCD (Association of University Centers on Disabilities) addresses concerns on the COVID-19 vaccine.

This project is sponsored in part by UCEDD Resource Center and National Center on Disability in Public Health, this paper provides information regarding:

Pre-Distribution considerations
Distribution guidance
Considerations for state and local disability leaders
AUCD Network Vaccine Tools and Resources

Click here to download this Frequently Asked Questions paper

Questions answered in this paper:

I. What is the federal approval process for a COVID-19 vaccine?
II. What is Operation Warp Speed and how does it impact the federal approval process for a COVID-19 vaccine?
III. What current vaccine developments are under way?
IV. I know a COVID-19 vaccine has not yet been approved for use, but has manufacturing started?
V. Has AUCD provided any guidance for COVID-19 vaccine distribution to federal and/or state governments?
VI. Have other organizations in the disability community provided any guidance for COVID-19 vaccine distribution to federal and/or state governments?
VII. What guidance has the federal government provided for COVID-19 vaccine distribution?
VIII. What guidance has my state provided for COVID-19 vaccine distribution?
IX. Where do I find my state’s plan?
X. My state has county and local health departments. Do they have separate plans?
XI. How will the vaccine be distributed at the local level?
XII. How can the AUCD network and your AUCD network center be poised to provide guidance to both the disability community and to state and local governments?
XIII. What should I be looking for in my review of the state COVID Vaccine plan?
XIV. After I have reviewed my state or local plan, how should I share my feedback and with whom?